Pharma and healthcare: sector news on Saturday 7 November 2026
Average tone +1.2 (neutral) across 3 companies with relevant coverage, from 28 stories.
How to read a score. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Company by company
| Company | Tone | Stories | What the coverage was about |
|---|---|---|---|
| GSK | +4.5 | 17 | Coverage was dominated by GSK settling its COVID and RSV vaccine patent dispute with Moderna without payments, which removes a legal overhang. |
| AstraZeneca | +4.5 | 9 | Most coverage concerned a reported takeover offer worth $10 billion for Rhythm Pharmaceuticals, a maker of obesity drugs; it was viewed as strategic, though investors were still assessing it. |
| Smith & Nephew | −5.3 | 2 | Coverage was mainly an analyst downgrade citing sluggish growth and a shifting outlook, which pulls sentiment negative. |
| Convatec | — | 0 | |
| Haleon | — | 0 |
Strongest stories in the sector
- +7.5 Indian subsidiary posts strong sales growth.
- +7.5 Indian subsidiary revenue growth driven by cancer medicines.
- +7.5 Indian unit's quarterly revenue rose strongly.
- +7.5 Removes a patent dispute with no payments required
- +7.5 Settlement covers both US and European disputes
- −7.5 Analyst downgrade citing slow growth and weaker outlook for the company.
- +7.3 Major legal overhang settled across COVID and RSV products
- +7.3 Repeat of the settlement news from a market data site
- +7.0 Litigation in Delaware brought to a close
- +5.8 Regulatory approval for cancer drug and valuation upside
- −4.2 Share price drifting down on selling
- −4.2 Shares dropped during the session on selling
Pharma and healthcare: every day · FTSE 100 overview for the day
Follow by email
A short, free morning email on how the news treated the Pharma and healthcare sector: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.